Here’s what you should know.
1. The company reported a 15 percent increase in year-over-year revenues.
2. The company’s gastrointestinal anesthesia services accounted for the majority of that revenue, approximately $22.11 million, a 19 percent year-over-year increase.
3. For the quarter, CRH serviced 57,657 patients, an increase of 36 percent year over year.
4. The company’s adjusted operating EBITDA was 12.41 million, a 12 percent year-over-year increase.
CRH CEO Edward Wright said, “We are extremely pleased with our first quarter results, which were positively impacted by the continued successful management and organic growth realized in the 16 anesthesia transactions we have integrated into CRH, in particular those acquired in 2017. The integration of Shreveport [La.], our most recent acquisition, and future acquisitions will continue to positively impact our business as we move forward.”
More articles on gastroenterology:
Allied Pain & Spine opens San Jose-based ASC: 4 key points
14 statistics on orthopedic, pain management net revenue per case at ASCs
4 things to know about Orthopaedic Research and Education Foundation’s new president Dr. Michael Parks
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
